{"id":7758,"date":"2025-09-01T12:24:06","date_gmt":"2025-09-01T12:24:06","guid":{"rendered":"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/?p=7758"},"modified":"2025-09-24T21:08:38","modified_gmt":"2025-09-24T21:08:38","slug":"new-paper-is-out-nanoscale-insights-into-therapeutic-antibody-function-with-resi-microscopy","status":"publish","type":"post","link":"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/new-paper-is-out-nanoscale-insights-into-therapeutic-antibody-function-with-resi-microscopy\/","title":{"rendered":"New paper is out! Nanoscale insights into therapeutic antibody function with RESI microscopy"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">We are proud to share the latest article co-authored by our lab member <strong>Ond\u0159ej Sko\u0159epa<\/strong>, titled:<br><strong>\u201c<a href=\"https:\/\/doi.org\/10.1038\/s41467-025-61893-w\">Resolving the structural basis of therapeutic antibody function in cancer immunotherapy with RESI<\/a>\u201d<\/strong>, published in Nature Communications!<\/p>\n\n\n\n<div class=\"wp-block-media-text is-stacked-on-mobile\"><figure  class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1843\" height=\"793\" alt=\"\" src=\"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-02-at-14.27.38-e1758748042359.png\" class=\"wp-image-7761 size-full\" srcset=\"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-02-at-14.27.38-e1758748042359.png 1843w, https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-02-at-14.27.38-e1758748042359-300x129.png 300w, https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-02-at-14.27.38-e1758748042359-1024x441.png 1024w, https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-02-at-14.27.38-e1758748042359-768x330.png 768w, https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-02-at-14.27.38-e1758748042359-1536x661.png 1536w\" sizes=\"auto, (max-width: 1843px) 100vw, 1843px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"wp-block-paragraph\">This study uncovers how the nanoscale organization of CD20 receptors determines the functional differences between Type I and Type II therapeutic anti-CD20 antibodies (such as Rituximab and Obinutuzumab). Using <strong>multi-target 3D RESI super-resolution microscopy<\/strong>, the authors achieved <strong>single-protein resolution<\/strong> in intact cells, revealing distinct receptor clustering patterns for Type I versus Type II antibodies.<\/p>\n<\/div><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Congratulations on this achievement!<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/doi.org\/10.1038\/s41467-025-61893-w\" data-type=\"link\" data-id=\"https:\/\/doi.org\/10.1038\/s41467-025-61893-w\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Pachmayr I., Masullo L. A., Reinhardt S. C. M., Kwon J., Llop M., <strong>Sko\u0159epa O.<\/strong>, Herter S., Bacac M., Klein C., Jungmann R. (2025): Resolving the structural basis of therapeutic antibody function in cancer immunotherapy with RESI. <em>Nat Commun<\/em> 16, 6768. <strong>IF 15.7<\/strong> DOI: 10.1038\/s41467-025-61893-w<\/mark><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>We are proud to share the latest article co-authored by our lab member Ond\u0159ej Sko\u0159epa, titled:\u201cResolving the structural basis of therapeutic antibody function in cancer immunotherapy with RESI\u201d, published in Nature Communications! This study uncovers how the nanoscale organization of CD20 receptors determines the functional differences between Type I and Type II therapeutic anti-CD20 antibodies [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":7761,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","footnotes":""},"categories":[16],"tags":[],"class_list":["post-7758","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publications"],"uagb_featured_image_src":{"full":["https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-02-at-14.27.38-e1758748042359.png",1843,793,false],"thumbnail":["https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-02-at-14.27.38-e1758748042359-150x150.png",150,150,true],"medium":["https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-02-at-14.27.38-e1758748042359-300x129.png",300,129,true],"medium_large":["https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-02-at-14.27.38-e1758748042359-768x330.png",640,275,true],"large":["https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-02-at-14.27.38-e1758748042359-1024x441.png",640,276,true],"1536x1536":["https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-02-at-14.27.38-e1758748042359-1536x661.png",1536,661,true],"2048x2048":["https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-02-at-14.27.38-e1758748042359.png",1843,793,false]},"uagb_author_info":{"display_name":"structimmuno","author_link":"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/author\/structimmuno\/"},"uagb_comment_info":0,"uagb_excerpt":"We are proud to share the latest article co-authored by our lab member Ond\u0159ej Sko\u0159epa, titled:\u201cResolving the structural basis of therapeutic antibody function in cancer immunotherapy with RESI\u201d, published in Nature Communications! This study uncovers how the nanoscale organization of CD20 receptors determines the functional differences between Type I and Type II therapeutic anti-CD20 antibodies&hellip;","_links":{"self":[{"href":"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-json\/wp\/v2\/posts\/7758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-json\/wp\/v2\/comments?post=7758"}],"version-history":[{"count":8,"href":"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-json\/wp\/v2\/posts\/7758\/revisions"}],"predecessor-version":[{"id":7782,"href":"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-json\/wp\/v2\/posts\/7758\/revisions\/7782"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-json\/wp\/v2\/media\/7761"}],"wp:attachment":[{"href":"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-json\/wp\/v2\/media?parent=7758"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-json\/wp\/v2\/categories?post=7758"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/web.natur.cuni.cz\/biochem\/structimmuno\/wp-json\/wp\/v2\/tags?post=7758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}